Heterogeneity of diabetes as a risk factor for major adverse cardiovascular events in anticoagulated patients with atrial fibrillation: an analysis of the ARISTOTLE trial.
De Caterina R, Patti G, Westerbergh J, Horowitz J, Ezekowitz JA, Lewis BS, Lopes RD, McMurray JJV, Atar D, Bahit MC, Keltai M, López-Sendón JL, Ruzyllo W, Granger CB, Alexander JH, Wallentin L.
De Caterina R, et al. Among authors: alexander jh.
Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):227-235. doi: 10.1093/ehjcvp/pvaa140.
Eur Heart J Cardiovasc Pharmacother. 2022.
PMID: 33367487
Clinical Trial.